Pharmacology, Toxicology and Pharmaceutical Science
Psilocybin
100%
Combination Therapy
100%
Inflammatory Bowel Disease
100%
Reactive Oxygen Metabolite
80%
Inflammation
60%
Psychotomimetic
55%
Drug Delivery System
40%
Side Effect
40%
Receptor
33%
Microdosing
22%
Crohn's Disease
20%
Ulcerative Colitis
20%
Chronic Inflammation
20%
Oral Drug Delivery
20%
Pathophysiology
20%
Nanocarrier
20%
Ileum
20%
Subcutaneous Injection
11%
Placebo
11%
Neuroscience
Psilocybin
100%
Lipidome
100%
Psychotomimetic
55%
Water Maze
25%
Mild Cognitive Impairment
25%
Hippocampus
25%
Cerebellum
25%
Cognitive Function
25%
Cerebral Cortex
25%
5-HT2A Receptor
22%
Thalamus
11%
Placebo
11%
Receptor Expression
11%
In Vivo
11%
Startle Response
11%
Psychedelic Drug
11%
Anhedonia
11%
Prepulse Inhibition
11%
Locomotor Activity
11%
5-HT7 Receptor
11%
Serotonergic
11%
Mental Disorder
11%
Medicine and Dentistry
Paraventricular Thalamic Nucleus
100%
Psilocybine
100%
Low Drug Dose
100%
Psychotomimetic
55%
Microdosing
22%
Drug Microdose
22%
Receptor
22%
Prepulse Inhibition
11%
Startle Response
11%
Subcutaneous Injection
11%
Anhedonia
11%
Mental Health
11%
Receptor Expression
11%
Thalamus
11%
Placebo Effect
11%
Mental Disorder
11%
